atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference | Psychedelic Invest

NEW YORK and BERLIN, May 23, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced the appointment of Scott Braunstein, M.D., and Laurent Fischer, M.D., as independent directors of atai’s supervisory board (“Board”) subject to applicable legal requirements. Scott…

Senate health committee advances changes to how FDA would approve new opioids

The Senate Health, Education, Labor and Pensions committee on Tuesday afternoon advanced three major bills related to the opioid epidemic and cancer screening, including an

December 14, 2023

Cancer Treatment Ups CV Risk; Therapy’s Next Big Thing; Nude Photos Settlement

Older adults treated for cancer had double the risk of cardiovascular (CV) events, including stroke, as compared with those without cancer, emphasizing the need for

September 27, 2024

Can the Mediterranean diet protect against childhood overweight and obesity?

Following the Mediterranean diet may modestly lower children’s risk of gaining excessive weight, but the impact was not statistically significant after adjusting for baseline factors.

October 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.